Article contents
Successful use of oral prostaglandin E1 derivative for maintaining ductus-dependent systemic circulation in a neonate with trisomy 18
Published online by Cambridge University Press: 22 August 2019
Abstract
A Japanese female infant with trisomy 18 was diagnosed with hypoplastic left heart syndrome variant. She was administered oral prostaglandin E1 every 6 hours through a feeding tube as an alternative drug for lipo-prostaglandin E1. Oral prostaglandin E1 was effective for maintenance of the ductus arteriosus and may serve as a palliative treatment approach.
- Type
- Brief Report
- Information
- Copyright
- © Cambridge University Press 2019
References
- 1
- Cited by